Autopsy report · NCT00418145

Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks

“low enrollment - data was not analyzed for this study”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 years 4 months after it had already started.
• Ran for about 10 years 1 month before it stopped.
• 16 participants enrolled.
• Results were posted on the registry 3 years 7 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Fred Lublin

Sponsor type

University, hospital or other

Conditions

Multiple Sclerosis

Interventions

megadose oral methylprednisolone; IV methylprednisolone

Participants

16

Sites

10

Countries

United States

Trials that died the same way

• Computer Assisted Volumetric Analysis of CT-Identified Metastatic Pulmonary Or Hepatic Lesions
  “Low participant enrollment, Insufficient findings for data analysis” (83% match in meaning)
• Duke Scleroderma Clinic Patient Registry
  “Low enrollment and no plans for analysis” (79% match in meaning)
• Pregabalin for Central Sensitization in TKA
  “Enrollment lower than anticipated; none of the subjects completing the study.” (77% match in meaning)
• Body Composition and Lifestyle Factors in ROTC
  “The study did not enroll participants” (77% match in meaning)
• Insulin Degludec for the Management of Patient With Recurrent Diabetic Ketoacidosis
  “Enrollment was too low to provide statistically significant data” (77% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.